Skip to main content
S&P 5007,706.03-0.75%DOW51,511.59-0.68%NASDAQ26,936.04-1.13%BTC$84,260.00-2.56%ETH$2,680.98-2.93%GOLD$4,329.80+0.26%OIL$91.55-0.66%
Smart Investors Daily
AC

NASDAQ · ACHC

Acadia Healthcare Company, Inc.

Healthcare · Medical - Care Facilities

$29.37

Down-$0.86 (-2.93%)

Updated Sep 24, 2026, 1:35 AM

SID Score

6.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.12B
P/E ratio
-1.92
Dividend yield
0.00%
52-week range
$11.43 – $35.83
Volume
2.06M
Avg. volume
3.8M

Price performance

ACHC price history

1M range · 19 trading sessions · Daily adjusted prices

ACHC closed at $29.37 after 19 trading sessions, down 3.96% for the selected period.

Last close
$29.37
Period change
-3.96%
Period low
$27.38
Period high
$30.58
Daily close
View OHLC price history
ACHC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 22, 2026$28.63$29.69$28.55$29.372.06M
Sep 21, 2026$28.33$29.14$28.31$28.371.49M
Sep 18, 2026$28.80$29.27$27.75$28.332.68M
Sep 17, 2026$28.63$29.08$28.16$28.811.55M
Sep 16, 2026$27.48$28.38$27.08$28.161.23M
Sep 15, 2026$27.94$28.03$26.97$27.381.19M
Sep 14, 2026$28.15$29.40$27.982$28.001.08M
Sep 11, 2026$28.96$29.26$28.23$28.36653.21K
Sep 10, 2026$27.86$29.80$27.82$28.531.09M
Sep 9, 2026$27.42$28.75$26.85$28.191.72M
Sep 8, 2026$27.71$28.45$27.445$27.501.32M
Sep 4, 2026$28.24$28.765$27.81$28.13835.04K
Sep 3, 2026$27.73$28.39$27.335$28.381.15M
Sep 2, 2026$28.19$28.59$27.50$27.751.14M
Sep 1, 2026$27.79$28.72$27.65$28.251.45M
Aug 31, 2026$28.27$28.545$27.49$27.562.08M
Aug 28, 2026$30.15$30.35$28.38$28.551.23M
Aug 27, 2026$30.14$30.55$29.39$30.221.32M
Aug 26, 2026$30.15$32.865$30.01$30.582.03M

Latest ACHC news

The latest Smart Investors Daily articles mentioning ACHC.

Stock researchCompany · Overview

ACHC research

Overview

Company profile and research snapshot.

Company profile

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$19.11
Implied upside
—
Analysts
—
ACHC recent ratings
DateFirmRatingTarget
Jul 30, 2026GuggenheimBuy—
Jul 30, 2026BarclaysEqual-Weight—
Jul 20, 2026GuggenheimBuy—
Jul 14, 2026TD CowenBuy—
Jul 14, 2026KeybancOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 18, 2026

Acadia Healthcare Company (ACHC) Heads To Jefferies Conference, Is It Still A Bargain?

Acadia Healthcare Company (ACHC) is in focus after management booked a slot at the 2026 Jefferies Healthcare Services and Technology Conference in Nashville, drawing fresh attention to the behavioral health operator. Recent trading has been strong for Acadia Healthcare Company, with a 1-day share price return of 2.31% and a 90-day share price return of 15.84% at a latest share price of US$28.81. However, the 3-year total shareholder return has declined 59.12%, showing short term momentum...

Yahoo · Sep 17, 2026

How Acadia’s Conference Push On Execution And Flexibility At Acadia Healthcare Company (ACHC) Has Changed Its Investment Story

Acadia Healthcare Company recently presented at the Jefferies Healthcare Services and Technology Conference on 14 September 2026 at 1 Hotel in Nashville, highlighting its behavioral health operations and outlook. The company emphasized strong underlying demand for mental health and substance use treatment alongside efforts to improve execution and earnings, supported by healthy cash generation and a valuable real estate portfolio. We’ll now examine how Acadia’s focus on execution...

Yahoo · Sep 9, 2026

2 Healthcare Stocks with Competitive Advantages and 1 We Question

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns as healthcare stocks have gained 25.7% over the past six months while the S&P 500 was up 13.6%.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By